DekaBank Deutsche Girozentrale raised its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 0.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,351,289 shares of the financial services provider's stock after buying an additional 12,506 shares during the quarter. DekaBank Deutsche Girozentrale owned about 0.20% of MetLife worth $105,305,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of MET. Ball & Co Wealth Management Inc. bought a new stake in MetLife in the fourth quarter valued at $25,000. Transce3nd LLC bought a new stake in shares of MetLife during the fourth quarter worth $26,000. North Capital Inc. acquired a new stake in MetLife in the first quarter worth about $26,000. Quarry LP acquired a new stake in MetLife in the fourth quarter worth about $31,000. Finally, Graney & King LLC acquired a new stake in MetLife in the fourth quarter worth about $34,000. 94.99% of the stock is currently owned by institutional investors.
MetLife Price Performance
Shares of MET traded down $0.68 during trading hours on Friday, hitting $77.69. 2,331,769 shares of the company were exchanged, compared to its average volume of 3,356,598. The company has a market cap of $52.15 billion, a price-to-earnings ratio of 12.63, a P/E/G ratio of 0.66 and a beta of 0.85. MetLife, Inc. has a fifty-two week low of $65.21 and a fifty-two week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.55. The firm's fifty day moving average is $78.98 and its 200 day moving average is $80.00.
MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). The company had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. MetLife had a return on equity of 20.89% and a net margin of 6.08%. The business's revenue for the quarter was up 15.6% compared to the same quarter last year. During the same period last year, the company posted $1.83 earnings per share. On average, equities analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th will be paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a yield of 2.92%. The ex-dividend date is Tuesday, August 5th. MetLife's dividend payout ratio (DPR) is presently 36.91%.
MetLife announced that its board has authorized a stock repurchase plan on Wednesday, April 30th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's leadership believes its stock is undervalued.
Analysts Set New Price Targets
MET has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. raised their target price on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a report on Tuesday. Morgan Stanley boosted their target price on MetLife from $94.00 to $99.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. UBS Group upped their price objective on MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, April 2nd. Wall Street Zen cut MetLife from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Piper Sandler increased their price target on MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $95.58.
Read Our Latest Analysis on MET
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.